Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023

Deutschland Nachrichten Nachrichten

Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
Deutschland Neuesten Nachrichten,Deutschland Schlagzeilen
  • 📰 AP
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 51%

Stocks that are trading heavily or have substantial price changes on Friday: Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall.

Amicus Therapeutics Inc. , up 35 cents to $12.21.Topgolf Callaway Brands Corp. , up 35 cents to $13.88.

The maker of golf equipment gave investors an encouraging production update following a fire last week.The biopharmaceutical company announced a contract with the U.S. for antibody research and development.The ski resort operator’s fiscal fourth-quarter loss was bigger than Wall Street expected.CEO Larry Fink reportedly said the investment firm is open to more acquisitions.Bain Capital is reportedly considering buying the auto insurance software company.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

AP /  🏆 728. in US

Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Structure Therapeutics shares surge after positive results in weight-loss trial, $300 million private placementStructure Therapeutics shares surge after positive results in weight-loss trial, $300 million private placementStructure Therapeutics Inc.’s American depositary receipts jumped more than 90% premarket on Friday after the company announced positive results from an...
Weiterlesen »

Brainstorm Cell Therapeutics shares fall more than 50% after FDA advisors vote down ALS treatmentBrainstorm Cell Therapeutics shares fall more than 50% after FDA advisors vote down ALS treatmentBrainStorm Cell Therapeutics Inc. shares fell 56% premarket on Thursday after advisors to the U.S. Food and Drug Administration on Wednesday gave a...
Weiterlesen »

FDA Panel Rejects Brainstorm Cell Therapeutics ALS TreatmentFDA Panel Rejects Brainstorm Cell Therapeutics ALS TreatmentBy Liz Essley Whyte A U.S. Food and Drug Administration advisory committee voted against a treatment from BrainStorm Cell Therapeutics for amyotrophic...
Weiterlesen »

Soleno Therapeutics Stock Dives After Its Meteoric Rise on Positive Study ResultsSoleno Therapeutics Stock Dives After Its Meteoric Rise on Positive Study ResultsThe biotechnology company had announced positive study results for its DCCR tablets on Tuesday.
Weiterlesen »

Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill dataShares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill dataStructure’s pill is part of the same class of drugs as Novo Nordisk’s blockbuster diabetes drug Ozempic and weight loss counterpart Wegovy.
Weiterlesen »

Postdoctoral Fellowship: Ocular Genetics, Genomics, & Therapeutics - Dallas, Texas (US) job with The University of Texas Southwestern Medical Center (UT Southwestern Medical Center)Postdoctoral Fellowship: Ocular Genetics, Genomics, & Therapeutics
Weiterlesen »



Render Time: 2025-02-27 16:47:41